DNAJC19P8

Across TCGA pan-cancer cohorts, DNAJC19P8 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated DNAJC19P8 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher DNAJC19P8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJC19P8 expression acts as an unfavorable survival marker, although some lineages such as LAML and ESCA show a favorable association.

OV, KICH, and LAML are the cancer types where DNAJC19P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	III,IV	0.479	0.586	.001	80	view →
KICH	DFS	Tertile	All	0.079	0.891	<.001	78	view →
LAML	DFS	Quartile	All	0.668	0.243	<.001	36	view →
CESC	OS	Tertile	IV	0.117	0.617	<.001	36	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
KIRC	DFS	Tertile	All	0.651	0.809	.032	18	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
PCPG	DFS	Tertile	All	0.112	0.769	.021	18	view →
LGG	DFS	Tertile	All	0.579	0.832	.003	15	view →
LUAD	DFS	Tertile	IV	0.671	0.893	.019	12	view →
STAD	OS	Median	All	0.336	0.502	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

DNAJC19P8–OV (DFS)

Open the OV breakdown →